Press Releases

Press Release

Hoth Therapeutics Announces the Selection of Altasciences for Manufacturing HT-TBI for Traumatic Brain Injury and Stroke

Sep 20, 2022

Press Release

Altasciences Receives 2022 CRO Leadership Award in Five Categories

May 2, 2022

Press Release

Alzamend Neuro Contracts with Altasciences and iResearch Atlanta to Manage and Conduct Its Phase IIA Study in Patients with Alzheimer’s

Apr 13, 2022

This is Alzamend Neuro's second study with Altasciences for the same program.

Press Release

Dr. Wendell P. Davis Joins Altasciences as Vice President, Pathology

Feb 7, 2022

Press Release

Altasciences Chosen by Virpax Pharmaceuticals, Inc. to Conduct First-in-Human Study of Epoladerm™ for Chronic Pain Associated with Osteoarthritis of the Knee

Jan 21, 2022

Press Release

Altasciences Acquires Sinclair Research and Continues to Expand Preclinical Platform

Jan 4, 2022

Press Release

Altasciences Chosen by Respira Technologies, Inc. as Drug Product Manufacturing Partner for the World’s First Inhaled Nicotine Replacement Therapy (NRT)

Dec 14, 2021